VIVARELLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.786
EU - Europa 3.921
AS - Asia 1.805
SA - Sud America 293
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 4
Totale 12.937
Nazione #
US - Stati Uniti d'America 6.720
UA - Ucraina 766
SG - Singapore 588
RU - Federazione Russa 572
IT - Italia 566
IE - Irlanda 526
DE - Germania 449
HK - Hong Kong 409
CN - Cina 351
BR - Brasile 264
TR - Turchia 253
DK - Danimarca 245
SE - Svezia 232
FI - Finlandia 215
KR - Corea 129
FR - Francia 126
GB - Regno Unito 108
CI - Costa d'Avorio 58
CA - Canada 47
MA - Marocco 33
IN - India 32
AT - Austria 22
RO - Romania 22
EU - Europa 18
MX - Messico 16
NL - Olanda 16
BE - Belgio 15
ZA - Sudafrica 12
CH - Svizzera 11
VE - Venezuela 8
UY - Uruguay 7
CZ - Repubblica Ceca 6
VN - Vietnam 6
PL - Polonia 5
UZ - Uzbekistan 5
AR - Argentina 4
AU - Australia 4
LT - Lituania 4
BD - Bangladesh 3
CO - Colombia 3
EC - Ecuador 3
ID - Indonesia 3
JP - Giappone 3
KZ - Kazakistan 3
PK - Pakistan 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
NP - Nepal 2
PE - Perù 2
SN - Senegal 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
ES - Italia 1
GH - Ghana 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
Totale 12.937
Città #
Jacksonville 815
Fairfield 753
Chandler 540
Dublin 526
Ashburn 485
Boardman 446
Hong Kong 407
Woodbridge 358
Wilmington 324
Seattle 312
Houston 298
Des Moines 275
Cambridge 233
New York 233
Singapore 224
Lawrence 183
Princeton 183
San Mateo 179
Ann Arbor 144
Moscow 125
The Dalles 105
Munich 100
Centro 95
Ancona 91
San Diego 84
Helsinki 72
Beijing 59
Abidjan 58
Ottawa 42
Los Angeles 41
Guangzhou 38
London 38
Turin 35
Shanghai 29
Redmond 26
Washington 26
São Paulo 24
Wuhan 23
Norwalk 22
Pune 22
Fermo 20
Appignano 18
Dallas 17
Milan 16
Brussels 15
Kilburn 15
Vienna 15
Osimo 14
Slobozia 14
Nuremberg 13
Jiaxing 12
Rome 11
Turku 11
Marche 10
Hounslow 9
Nanjing 9
Porto 9
Santa Clara 9
Bellante 8
Johannesburg 8
San Benedetto del Tronto 8
Wuxi 8
Belo Horizonte 7
Brasília 7
Civitanova Marche 7
Mexico City 7
Prescot 7
San Francisco 7
Shenzhen 7
Tolentino 7
Wiezikon 7
Bologna 6
New Bedfont 6
Rio de Janeiro 6
Berlin 5
Boydton 5
Castelfidardo 5
Dong Ket 5
Falls Church 5
Guarulhos 5
Jinhua 5
Pesaro 5
Tashkent 5
Brooklyn 4
Cape Town 4
Dearborn 4
Falconara Marittima 4
Fayetteville 4
Goiânia 4
Hangzhou 4
Jinan 4
Montreal 4
Naples 4
Olomouc 4
Redwood City 4
San Benedetto Del Tronto 4
São Bernardo do Campo 4
São José dos Campos 4
Zhengzhou 4
Almaty 3
Totale 8.535
Nome #
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 225
Human white adipocytes convert into “rainbow” adipocytes in vitro 206
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 148
Are liver nested stromal epithelial tumors always low aggressive? 124
ALPPS Procedure for extended liver resections: A single centre experience and a systematic review 123
Infrarenal versus supraceliac aorto-hepatic arterial revascularisation in adult liver transplantation: multicentre retrospective study 122
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study 116
Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same? 114
Advances in hepatobiliary surgery: The ancona’s experience with ALPPS procedure for extended liver resections 113
Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: report of a first case. 111
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 109
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer. 106
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 105
Liver transplantation for hepatocellular carcinoma on cirrhosis: Strategies to avoid tumor recurrence. 103
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 103
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure among Patients Requiring Early Liver Retransplant 102
Importance of radiological detection of early pulmonary acute complications of liver transplantation: analysis of 259 cases 101
Fast track program in liver resection: A PRISMA-compliant systematic review and meta-analysis 98
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 95
Immunological risk factors in biliary strictures after liver transplantation 95
Predictive factors of short term outcome after liver transplantation: A review 95
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score 95
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. 95
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 95
The role of the comprehensive complication index for the prediction of survival after liver transplantation 94
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning 92
Liver transplantation in patients with common variable immunodeficiency: a report of two cases 92
Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients 91
Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area 91
Delayed Intracerebral Hemorrhage After Pseudoaneurysm of Middle Meningeal Artery Rupture: Case Report, Literature Review, and Forensic Issues 90
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 90
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 89
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 89
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study 89
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 88
Abstension from treatment of low-level pp65 cytomegalovirus antigenemia after liver transplantation: a prospective study 87
Bone marrow adipocytes support haematopoietic stem cell survival 87
A national mandatory-split liver policy: A report from the Italian experience. 86
L’ansa alla Roux nella chirurgia pancreatica 83
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 83
Is portal hypertension a contraindication to hepatic resection? 82
Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver Transplantation 81
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 81
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 80
Impact of aberrant left hepatic artery ligation on the outcome of liver transplantation 80
The role of imaging in surgical planning for liver resection: What the radiologist needs to know 80
Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012-2014. 79
HIV-infected patients and liver transplantation: who, when and why. 78
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 78
Controlling Nutritional Status score does not predict patients' overall survival or hepatocellular carcinoma recurrence after deceased donor liver transplantation 77
Outcomes of robotic vs laparoscopic hepatectomy: A systematic review and meta-analysis 76
Resected biliary tract cancers: A novel clinical-pathological score correlates with global outcome 76
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 75
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 75
Outcome after laparoscopic and open resections of posterosuperior segments of the liver. 75
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study. 75
Laparoscopic versus open right posterior sectionectomy: an international, multicenter, propensity score-matched evaluation 75
Liver transplantation in neurological Wilson's Disease: is there indication? A case report 74
The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection 73
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 71
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression 71
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 70
Metastatic breast cancer mimicking a hilar cholangiocarcinoma: case report and review of the literature. 69
Autoantibody appearance in cytomegalovirus-infected liver transplant recipient: correlation with antigenemia 68
RADIOLOGICAL RESPONSE AND INFLAMATION SCORES PREDICT TUMOR RECURRENCE IN PATIENT TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION BEFORE LIVER TRANSPLANTATION 68
Minimally Invasive Stage 1 to Protect against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry 68
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease 67
Robotic versus laparoscopic resections of posterosuperior segments of the liver: a propensity score-matched comparison 67
Surgery for cholangiocarcinoma 67
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver 66
Complications of liver transplantation 66
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation. 66
A new liver transplant priority for patients with hepatocellular carcinoma 65
Point of care perioperative coagulation management in liver transplantation and complete portal vein thrombosis 65
Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation 65
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 65
Successful arterial revascularization in liver transplantation using a cryopreserved arterial allograft 64
IMPACT OF ABERRANT LEFT HEPATIC ARTERY LIGATION ON OUTCOME AFTER LIVER TRANSPLANTATION 64
Bleeding Esophageal Varices: Today's Role of Portosystemic Shunts 63
Attuali orientamenti nella terapia chirurgica della idatidosi epatica 63
Tecnica chirurgica del trapianto di fegato 63
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 63
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience 62
Spontaneous portal vein arterialization in hepatic artery thrombosis. 61
Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature. 60
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis 59
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation 57
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 57
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period 57
Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography 57
Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? 57
Erratum to "A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list" [JHepatol 2013;60:290-297]. 57
Rise and fall of HCV-related hepatocellular carcinoma in Italy: A long-term survey from the ITA.LI.CA centres 57
Sirolimus in liver transplant recipients: a large single-center experience 56
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor 56
Sepsis and pleural effusion due to a multiresistant Listeria monocytogenes strain after an orthotopic liver transplantation 56
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 56
Indocyanine Green Fluorescence Navigation in Liver Surgery: A Systematic Review on Dose and Timing of Administration 55
Donor pool expansion in liver transplantation 55
Influence of steroids on HCV recurrence after liver transplantation: A prospective study 55
Totale 8.244
Categoria #
all - tutte 85.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 0 0 0 0 0 0 44 276
2020/20213.153 181 322 371 100 414 174 264 240 278 371 289 149
2021/20221.319 94 261 29 26 12 133 34 97 95 138 112 288
2022/20231.988 215 208 141 118 110 367 22 84 523 9 114 77
2023/20241.590 237 24 132 245 259 339 27 37 13 41 28 208
2024/20252.965 283 318 113 42 98 167 259 276 955 302 152 0
Totale 13.262